Moxe announced recently that its clinical data clearinghouse platform called Substrate is verified to interface with Epic’s EHR. According to a release, health systems on Epic’s EHR will be able to securely share vital medical information with the nation’s leading health plans. “Moxe is committed to furthering interoperability in...
MADISON, Wis., Oct. 14, 2019 – Exact Sciences Corp. today announced that, in collaboration with Mayo Clinic, it has initiated the Voyage study to generate evidence of the real-world impact of Cologuard on colorectal cancer screening, incidence, and mortality rates. Voyage is a prospective, observational study...
UW-Madison researchers involved in two Madison-based stem cell companies have received a federal grant to test experimental therapies for heart failure in pigs. The $765,000 grant, announced last week, will allow Dr. Amish Raval, co-founder of Cellular Logistics, and Dr. Tim Kamp, a founder of and consultant...
Cellectar Biosciences’ cancer therapy has received “orphan drug” designation from the European Commission for the treatment of multiple myeloma, a cancer of the body’s plasma cells. “This designation complements our U.S. orphan drug designation and U.S. fast track designation already granted by the FDA,” said company...
Burn wounds treated in a clinical trial with skin tissue made by the Madison company Stratatech mostly healed well and rarely required patient skin grafts, findings that will spur an application for federal approval next year, the company said last week. Stratatech, bought in 2016 for $76 million by...
Imbed Biosciences, a medical device company that is developing advanced therapies for soft tissue repair, has received a $1.5 million, two-year Small Business Innovation Research (SBIR) grant, the University of Wisconsin announced today. According to a release, the grant will help test whether adding gallium metal...
MADISON, Wis.--Redox today announced its third annual Healthcare Interoperability Summit, which will take place on Oct. 15, 2019 at the Aloft Boston Seaport Hotel. The conference brings together the most influential health IT professionals from around the country for a deep dive into one of the biggest...
MADISON, Wis. (WMTV) - Exact Sciences announced the U.S. Food and Drug Administration (FDA) has approved the expansion of its colorectal cancer screening test Cologuard to people between the ages of 45 and 49. Previously, Cologuard was only approved for adults 50 years or older. This reflects...
MADISON, WI. SEPT. 20, 2019 – Catalent Biologics’ cell line development and biomanufacturing site in Madison is expanding with a $75 million investment expected to create at least 145 new jobs by the end of 2021, Governor Tony Evers, local leaders and company officials announced today. “We...
FUJIFILM Cellular Dynamics (FCDI) today unveiled its new 32,000-sq.ft. cell therapeutics facility at 465 Science Dr. that has been named i-FACT (Innovation Facility for Advanced Cell Therapies). It marked a milestone for FUJIFILM since it acquired Cellular Dynamics in 2015. At the time, FUJIFILM announced it would...